The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gultyaeva V.V.

Research Institute of Physiology and Basic Medicine, Novosibirsk, Russia

Zinchenko M.I.

Research Institute of Physiology and Basic Medicine, Novosibirsk, Russia

Uryumtsev D.Y.

Research Institute of Physiology and Basic Medicine, Novosibirsk, Russia

Krivoschekov S.G.

Research Institute of Physiology and Basic Medicine, Novosibirsk, Russia

Aftanas L.I.

Research Institute of Physiology and Basic Medicine, Novosibirsk, Russia

Exercise for depression treatment. Physiological mechanisms

Authors:

Gultyaeva V.V., Zinchenko M.I., Uryumtsev D.Y., Krivoschekov S.G., Aftanas L.I.

More about the authors

Read: 13250 times


To cite this article:

Gultyaeva VV, Zinchenko MI, Uryumtsev DY, Krivoschekov SG, Aftanas LI. Exercise for depression treatment. Physiological mechanisms. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(7):112‑119. (In Russ.)
https://doi.org/10.17116/jnevro2019119071112

Recommended articles:
Pathogenetic inte­rrelations of hypo­gonadism and depression in men. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):17-23
Asthenia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):5-10
Factors of depression acco­rding to acti­graphy in the fall season. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):27-32
Identification of depression biomarkers: Prospects for use in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):51-55
The effect of a gami­fication on healthy indi­viduals’ motor acti­vity. Russian Journal of Preventive Medi­cine. 2025;(4):111-116

References:

  1. Bykov YuV. Therapy resistant depressions. Stavropol: Idea+; 2009. (In Russ.)
  2. Ceskova E, Silhan P. Novel treatment options in depression and psychosis. Neuropsychiatr Dis Treat. 2018;14:741-747. https://doi.org/10.2147/NDT.S157475
  3. Ahmed AT, Weinshilboum R, Frye MA. Benefits of and barriers to pharmacogenomics-guided treatment for major depressive disorder. Clin Pharmacol Ther. 2018. https://doi.org/10.1002/cpt.1009
  4. Hengartner MP. Methodological flaws, conflicts of interest, and scientific fallacies: implications for the evaluation of antidepressants’ efficacy and harm. Front Psychiatry. 2017;8:275. https://doi.org/10.3389/fpsyt.2017.00275
  5. Pedersen BK, Saltin B. Exercise as medicine — evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015;25(suppl 3):1-72. https://doi.org/10.1111/sms.12581
  6. Stubbs B, Vancampfort D, Firth J, Schuch FB, Hallgren M, Smith L, Gardner B, Kahl KG, Veronese N, Solmi M, Carvalho AF, Koyanagi A. Relationship between sedentary behavior and depression: a mediation analysis of influential factors across the lifespan among 42,469 people in low- and middle-income countries. J Affect Disord. 2018;229:231-238. https://doi.org/10.1016/j.jad.2017.12.104
  7. Vancampfort D, Stubbs B, Mugisha J, Firth J, Schuch FB, Koyanagi A. Correlates of sedentary behavior in 2,375 people with depression from 6 low- and middle-income countries. J Affect Disord. 2018;234:97-104. https://doi.org/10.1016/j.jad.2018.02.088
  8. Becofsky KM, Sui X, Lee DC, Wilcox S, Zhang J, Blair SN. A prospective study of fitness, fatness, and depressive symptoms. Am J Epidemiol. 2015;181(5):311-320. https://doi.org/10.1093/aje/kwu330
  9. de Oliveira GD, Oancea SC, Nucci LB, Vogeltanz-Holm N. The association between physical activity and depression among individuals residing in Brazil. Soc Psychiatry Psychiatr Epidemiol. 2018;53(4):373-383. https://doi.org/10.1007/s00127-017-1441-6
  10. Schuch FB, Vancampfort D, Firth J, Rosenbaum S, Ward PB, Silva ES, Hallgren M, Ponce De Leon A, Dunn AL, Deslandes AC, Fleck MP, Carvalho AF, Stubbs B. Physical activity and incident depression: a meta-analysis of prospective cohort studies. Am J Psychiatry. 2018:appiajp201817111194. https://doi.org/10.1176/appi.ajp.2018.17111194
  11. Schuch FB, Vancampfort D, Richards J, Rosenbaum S, Ward PB, Stubbs B. Exercise as a treatment for depression: a meta-analysis adjusting for publication bias. J Psychiatr Res. 2016;77:42-51. https://doi.org/10.1016/j.jpsychires.2016.02.023
  12. Penninx BW. Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms. Neurosci Biobehav Rev. 2017;74(Pt B):277-286. https://doi.org/10.1016/j.neubiorev.2016.07.003
  13. Vancampfort D, Correll CU, Galling B, Probst M, De Hert M, Ward PB, Rosenbaum S, Gaughran F, Lally J, Stubbs B. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry. 2016;15(2):166-174. https://doi.org/10.1002/wps.20309
  14. Siqueira CC, Valiengo LL, Carvalho AF, Santos-Silva PR, Missio G, de Sousa RT, Di Natale G, Gattaz WF, Moreno RA, Machado-Vieira R. Antidepressant efficacy of adjunctive aerobic activity and associated biomarkers in major depression: a 4-week, randomized, single-blind, controlled clinical trial. PLoS One. 2016;11(5):e0154195. https://doi.org/10.1371/journal.pone.0154195
  15. Gourgouvelis J, Yielder P, Clarke ST, Behbahani H, Murphy BA. Exercise Leads to better clinical outcomes in those receiving medication plus cognitive behavioral therapy for major depressive disorder. Front Psychiatry. 2018;9:37. https://doi.org/10.3389/fpsyt.2018.00037
  16. Busch AM, Ciccolo JT, Puspitasari AJ, Nosrat S, Whitworth JW, Stults-Kolehmainen M. Preferences for exercise as a treatment for depression. Ment Health Phys Act. 2016;10:68-72. https://doi.org/10.1016/j.mhpa.2015.12.004
  17. Gonda X, Hullam G, Antal P, Eszlari N, Petschner P, Hokfelt TG, Anderson IM, Deakin JFW, Juhasz G, Bagdy G. Significance of risk polymorphisms for depression depends on stress exposure. Sci Rep. 2018;8(1):3946. https://doi.org/10.1038/s41598-018-22221-z
  18. Grigoryan GA, Gulyaeva NV. Stress reactivity and stress-resilience in the pathogenesis of depressive disorders: involvement of epigenetic mechanisms. The I.P. Pavlov Journal of Higher Nervous Activity. 2015;65(1):19-32. (In Russ.) https://doi.org/10.7868/S0044467715010037
  19. Shishkina GT, Dygalo NN. The glucocorticoid hypothesis of depression: history and perspectives. The Vavilov Journal of Genetics and Selection. 2016;20(2):198-203. (In Russ.) https://doi.org/10.18699/VJ16.155
  20. Liu B, Liu J, Wang M, Zhang Y, Li L. From serotonin to neuroplasticity: evolvement of theories for major depressive disorder. Front Cell Neurosci. 2017;11:305. https://doi.org/10.3389/fncel.2017.00305
  21. Petschner P, Gonda X, Baksa D, Eszlari N, Trivaks M, Juhasz G, Bagdy G. Genes linking mitochondrial function, cognitive impairment and depression are associated with endophenotypes serving precision medicine. Neuroscience. 2018;370:207-217. https://doi.org/10.1016/j.neuroscience.2017.09.049
  22. Sharma S, Akundi RS. Mitochondria: a connecting link in the major depressive disorder jigsaw. Curr Neuropharmacol. 2018. https://doi.org/10.2174/1570159X16666180302120322
  23. Andrews PW, Bharwani A, Lee KR, Fox M, Thomson JA, Jr. Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response. Neurosci Biobehav Rev. 2015;51:164-188. https://doi.org/10.1016/j.neubiorev.2015.01.018
  24. Culverhouse RC, Saccone NL, Horton AC, Ma Y, Anstey KJ, Banaschewski T, Burmeister M, Cohen-Woods S, Etain B, Fisher HL, Goldman N, Guillaume S, Horwood J, Juhasz G, Lester KJ, Mandelli L, Middeldorp CM, Olie E, Villafuerte S, Air TM, Araya R, Bowes L, Burns R, Byrne EM, Coffey C, Coventry WL, Gawronski KAB, Glei D, Hatzimanolis A, Hottenga JJ, Jaussent I, Jawahar C, Jennen-Steinmetz C, Kramer JR, Lajnef M, Little K, Zu Schwabedissen HM, Nauck M, Nederhof E, Petschner P, Peyrot WJ, Schwahn C, Sinnamon G, Stacey D, Tian Y, Toben C, Van der Auwera S, Wainwright N, Wang JC, Willemsen G, Anderson IM, Arolt V, Aslund C, Bagdy G, Baune BT, Bellivier F, Boomsma DI, Courtet P, Dannlowski U, de Geus EJC, Deakin JFW, Easteal S, Eley T, Fergusson DM, Goate AM, Gonda X, Grabe HJ, Holzman C, Johnson EO, Kennedy M, Laucht M, Martin NG, Munafo MR, Nilsson KW, Oldehinkel AJ, Olsson CA, Ormel J, Otte C, Patton GC, Penninx B, Ritchie K, Sarchiapone M, Scheid JM, Serretti A, Smit JH, Stefanis NC, Surtees PG, Volzke H, Weinstein M, Whooley M, Nurnberger JI Jr, Breslau N, Bierut LJ. Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression. Mol Psychiatry. 2018;23(1):133-142. https://doi.org/10.1038/mp.2017.44
  25. Gujral S, Aizenstein H, Reynolds CF, Butters MA, Erickson KI. Exercise effects on depression: possible neural mechanisms. General Hospital Psychiatry. 2017;49:2-10. https://doi.org/10.1016/j.genhosppsych.2017.04.012
  26. Rolls ET, Cheng W, Gilson M, Qiu J, Hu Z, Ruan H, Li Y, Huang CC, Yang AC, Tsai SJ, Zhang X, Zhuang K, Lin CP, Deco G, Xie P, Feng J. Effective connectivity in depression. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3(2):187-197. https://doi.org/10.1016/j.bpsc.2017.10.004
  27. Knyazev GG, Savostyanov AN, Bocharov AV, Brak IV, Osipov EA, Filimonova EA, Saprigyn AE, Aftanas LI. Task-positive and task-negative networks in major depressive disorder: A combined fMRI and EEG study. J Affect Disord. 2018;235:211-219. https://doi.org/10.1016/j.jad.2018.04.003
  28. Phillips C. Brain-derived neurotrophic factor, depression, and physical activity: making the neuroplastic connection. Neural Plast. 2017;2017:7260130. https://doi.org/10.1155/2017/7260130
  29. Bansal Y, Kuhad A. Mitochondrial dysfunction in depression. Curr Neuropharmacol. 2016;14(6):610-618.
  30. Iwata M, Ota KT, Duman RS. The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun. 2013;31:105-114. https://doi.org/10.1016/j.bbi.2012.12.008
  31. Kaufmann FN, Costa AP, Ghisleni G, Diaz AP, Rodrigues ALS, Peluffo H, Kaster MP. NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings. Brain Behav Immun. 2017;64:367-383. https://doi.org/10.1016/j.bbi.2017.03.002
  32. Kim YK, Na KS, Myint AM, Leonard BE. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2016;64:277-284. https://doi.org/10.1016/j.pnpbp.2015.06.008
  33. Levchuk LA, Vyalova NM, Simutkin GG, Bokhan NA, Ivanova SA. Neurohumoral markers that predict the efficiency of pharmacologic therapy of depressive disorders. Neurochemical Journal. 2017;34(2):177-180. (In Russ.) https://doi.org/10.7868/S1027813317020091
  34. Grigoryan GA, Dygalo NN, Guekht AB, Stepanichev MYu, Gulyaeva NV. Molecular and cellular mechanisms of depression. Role of glucocorticoids, cytokines, neurotransmitters, and trophic factors in genesis depressive disorders. Achievements of Physiological Sciences. 2014;45(2):3-19. (In Russ.)
  35. Boiko AS, Losenkov IS, Levchuk LA, Simutkin GG, Ivanova SA. Multiplex approach in depressive disorders research. Opera Med Physiol. 2016;2(1):33-34.
  36. Wang AK, Miller BJ. Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression. Schizophr Bull. 2018;44(1):75-83. https://doi.org/10.1093/schbul/sbx035
  37. Phillips C, Fahimi A. Immune and neuroprotective effects of physical activity on the brain in depression. Front Neurosci. 2018;12:498. https://doi.org/10.3389/fnins.2018.00498
  38. Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology. 2012;62(1):63-77. https://doi.org/10.1016/j.neuropharm.2011.07.036
  39. Mahar I, Bambico FR, Mechawar N, Nobrega JN. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neurosci Biobehav Rev. 2014;38:173-192. https://doi.org/10.1016/j.neubiorev.2013.11.009
  40. Pizzagalli DA. Depression, stress, and anhedonia: toward a synthesis and integrated model. Annual Review of Clinical Psychology. 2014;10:393-423. https://doi.org/10.1146/annurev-clinpsy-050212-185606
  41. Reus GZ, Jansen K, Titus S, Carvalho AF, Gabbay V, Quevedo J. Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: evidences from animal and human studies. J Psychiatr Res. 2015;68:316-328. https://doi.org/10.1016/j.jpsychires.2015.05.007
  42. Czeh B, Nagy SA. Clinical findings documenting cellular and molecular abnormalities of glia in depressive disorders. Front Mol Neurosci. 2018;11:56. https://doi.org/10.3389/fnmol.2018.00056
  43. Robinson ESJ. Translational new approaches for investigating mood disorders in rodents and what they may reveal about the underlying neurobiology of major depressive disorder. Philos Trans R Soc Lond B Biol Sci. 2018;373(1742). https://doi.org/10.1098/rstb.2017.0036
  44. Heinzel S, Rapp MA, Fydrich T, Strohle A, Teran C, Kallies G, Schwefel M, Heissel A. Neurobiological mechanisms of exercise and psychotherapy in depression: the SPeED study-rationale, design, and methodological issues. Clin Trials. 2018;15(1):53-64. https://doi.org/10.1177/1740774517729161
  45. Mikkelsen K, Stojanovska L, Polenakovic M, Bosevski M, Apostolopoulos V. Exercise and mental health. Maturitas. 2017;106:48-56. https://doi.org/10.1016/j.maturitas.2017.09.003
  46. Fiuza-Luces C, Garatachea N, Berger NA, Lucia A. Exercise is the real polypill. Physiology (Bethesda). 2013;28(5):330-358. https://doi.org/10.1152/physiol.00019.2013
  47. Huh JY. The role of exercise-induced myokines in regulating metabolism. Arch Pharm Res. 2018;41(1):14-29. https://doi.org/10.1007/s12272-017-0994-y
  48. Voss MW, Erickson KI, Prakash RS, Chaddock L, Kim JS, Alves H, Szabo A, Phillips SM, Wojcicki TR, Mailey EL, Olson EA, Gothe N, Vieira-Potter VJ, Martin SA, Pence BD, Cook MD, Woods JA, McAuley E, Kramer AF. Neurobiological markers of exercise-related brain plasticity in older adults. Brain Behav Immun. 2013;28:90-99. https://doi.org/10.1016/j.bbi.2012.10.021
  49. Chieffi S, Messina G, Villano I, Messina A, Esposito M, Monda V, Valenzano A, Moscatelli F, Esposito T, Carotenuto M, Viggiano A, Cibelli G, Monda M. Exercise influence on hippocampal function: possible involvement of orexin-A. Front Physiol. 2017;8:85. https://doi.org/10.3389/fphys.2017.00085
  50. Rendeiro C, Rhodes JS. A new perspective of the hippocampus in the origin of exercise-brain interactions. Brain Struct Funct. 2018. https://doi.org/10.1007/s00429-018-1665-6
  51. Firth J, Stubbs B, Vancampfort D, Schuch F, Lagopoulos J, Rosenbaum S, Ward PB. Effect of aerobic exercise on hippocampal volume in humans: a systematic review and meta-analysis. Neuroimage. 2018;166:230-238. https://doi.org/10.1016/j.neuroimage.2017.11.007
  52. Shohayeb B, Diab M, Ahmed M, Ng DCH. Factors that influence adult neurogenesis as potential therapy. Transl Neurodegener. 2018;7:4. https://doi.org/10.1186/s40035-018-0109-9
  53. Raichlen DA, Polk JD. Linking brains and brawn: exercise and the evolution of human neurobiology. Proc Biol Sci. 2013;280(1750):20122250. https://doi.org/10.1098/rspb.2012.2250
  54. Raefsky SM, Mattson MP. Adaptive responses of neuronal mitochondria to bioenergetic challenges: roles in neuroplasticity and disease resistance. Free Radic Biol Med. 2017;102:203-216. https://doi.org/10.1016/j.freeradbiomed.2016.11.045
  55. Marosi K, Mattson MP. BDNF mediates adaptive brain and body responses to energetic challenges. Trends Endocrinol Metab. 2014;25(2):89-98. https://doi.org/10.1016/j.tem.2013.10.006
  56. Hurtado E, Cilleros V, Nadal L, Simo A, Obis T, Garcia N, Santafe MM, Tomas M, Halievski K, Jordan CL, Lanuza MA, Tomas J. Muscle contraction regulates BDNF/TrkB signaling to modulate synaptic function through presynaptic cPKCalpha and cPKCbetaI. Front Mol Neurosci. 2017;10:147. https://doi.org/10.3389/fnmol.2017.00147
  57. Phillips C. Physical Activity modulates common neuroplasticity substrates in major depressive and bipolar disorder. Neural Plast. 2017;7014146. https://doi.org/10.1155/2017/7014146
  58. Rasmussen P, Brassard P, Adser H, Pedersen MV, Leick L, Hart E, Secher NH, Pedersen BK, Pilegaard H. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol. 2009;94(10):1062-1069. https://doi.org/10.1113/expphysiol.2009.048512
  59. Dinoff A, Herrmann N, Swardfager W, Liu CS, Sherman C, Chan S, Lanctot KL. The effect of exercise training on resting concentrations of peripheral brain-derived neurotrophic factor (BDNF): a meta-analysis. PLoS One. 2016;11(9):e0163037. https://doi.org/10.1371/journal.pone.0163037
  60. Dinoff A, Herrmann N, Swardfager W, Lanctot KL. The effect of acute exercise on blood concentrations of brain-derived neurotrophic factor in healthy adults: a meta-analysis. Eur J Neurosci. 2017;46(1):1635-1646. https://doi.org/10.1111/ejn.13603
  61. Meyer JD, Koltyn KF, Stegner AJ, Kim JS, Cook DB. Relationships between serum BDNF and the antidepressant effect of acute exercise in depressed women. Psychoneuroendocrinology. 2016;74:286-294. https://doi.org/10.1016/j.psyneuen.2016.09.022
  62. Pereira DS, de Queiroz BZ, Miranda AS, Rocha NP, Felicio DC, Mateo EC, Favero M, Coelho FM, Jesus-Moraleida F, Gomes Pereira DA, Teixeira AL, Maximo Pereira LS. Effects of physical exercise on plasma levels of brain-derived neurotrophic factor and depressive symptoms in elderly women a randomized clinical trial. Arch Phys Med Rehabil. 2013;94(8):1443-1450. https://doi.org/10.1016/j.apmr.2013.03.029
  63. Lee IT, Fu CP, Lee WJ, Liang KW, Lin SY, Wan CJ, Sheu WH. Brain-derived neurotrophic factor, but not body weight, correlated with a reduction in depression scale scores in men with metabolic syndrome: a prospective weight-reduction study. Diabetol Metab Syndr. 2014;6(1):18. https://doi.org/10.1186/1758-5996-6-18
  64. Muller P, Rehfeld K, Schmicker M, Hokelmann A, Dordevic M, Lessmann V, Brigadski T, Kaufmann J, Muller NG. Evolution of neuroplasticity in response to physical activity in old age: the case for dancing. Front Aging Neurosci. 2017;9:56. https://doi.org/10.3389/fnagi.2017.00056
  65. Gourgouvelis J, Yielder P, Murphy B. Exercise promotes neuroplasticity in both healthy and depressed brains: an fMRI pilot study. Neural Plast. 2017;8305287. https://doi.org/10.1155/2017/8305287
  66. Sleiman SF, Henry J, Al-Haddad R, El Hayek L, Abou Haidar E, Stringer T, Ulja D, Karuppagounder SS, Holson EB, Ratan RR, Ninan I, Chao MV. Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body beta-hydroxybutyrate. Elife. 2016;5. https://doi.org/10.7554/eLife.15092
  67. Dikalov SI, Mayorov VI, Panov AV. Physiological levels of nitric oxide diminish mitochondrial superoxide. potential role of mitochondrial dinitrosyl iron complexes and nitrosothiols. Front Physiol. 2017;8:907. https://doi.org/10.3389/fphys.2017.00907
  68. Hasegawa N, Fujie S, Horii N, Miyamoto-Mikami E, Tsuji K, Uchida M, Hamaoka T, Tabata I, Iemitsu M. Effects of different exercise modes on arterial stiffness and nitric oxide synthesis. Med Sci Sports Exerc. 2018;50(6):1 177-1185. https://doi.org/10.1249/MSS.0000000000001567
  69. Schuch FB, Deslandes AC, Stubbs B, Gosmann NP, Silva CT, Fleck MP. Neurobiological effects of exercise on major depressive disorder: a systematic review. Neurosci Biobehav Rev. 2016;61:1-11. https://doi.org/10.1016/j.neubiorev.2015.11.012
  70. Boppart MD, De Lisio M, Witkowski S. Exercise and stem cells. Prog Mol Biol Transl Sci. 2015;135:423-456. https://doi.org/10.1016/bs.pmbts.2015.07.005
  71. Ratajczak MZ, Ciechanowicz AK, Kucharska-Mazur J, Samochowiec J. Stem cells and their potential clinical applications in psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2018;80(Pt A):3-9. https://doi.org/10.1016/j.pnpbp.2017.04.020
  72. Lavebratt C, Herring MP, Liu JJ, Wei YB, Bossoli D, Hallgren M, Forsell Y. Interleukin-6 and depressive symptom severity in response to physical exercise. Psychiatry Res. 2017;252:270-276. https://doi.org/10.1016/j.psychres.2017.03.012
  73. Zschucke E, Renneberg B, Dimeo F, Wustenberg T, Strohle A. The stress-buffering effect of acute exercise: evidence for HPA axis negative feedback. Psychoneuroendocrinology. 2015;51:414-425. https://doi.org/10.1016/j.psyneuen.2014.10.019
  74. Plag J, Gaudlitz K, Schumacher S, Dimeo F, Bobbert T, Kirschbaum C, Strohle A. Effect of combined cognitive-behavioural therapy and endurance training on cortisol and salivary alpha-amylase in panic disorder. Journal of Psychiatric Research. 2014;58:12-19. https://doi.org/10.1016/j.jpsychires.2014.07.008
  75. Dremencov E, Csatlosova K, Durisova B, Moravcikova L, Lacinova L, Jezova D. Effect of physical exercise and acute escitalopram on the excitability of brain monoamine neurons: in vivo electrophysiological study in rats. Int J Neuropsychopharmacol. 2017;20(7):585-592. https://doi.org/10.1093/ijnp/pyx024
  76. Brand S, Colledge F, Ludyga S, Emmenegger R, Kalak N, Sadeghi Bahmani D, Holsboer-Trachsler E, Puhse U, Gerber M. Acute bouts of exercising improved mood, rumination and social interaction in inpatients with mental disorders. Front Psychol. 2018;9:249. https://doi.org/10.3389/fpsyg.2018.00249
  77. Aftanas LI, Bazanova OM, Novozhilova NV. Posture-motor and posture-ideomotor dual-tasking: a putative marker of psychomotor retardation and depressive rumination in patients with major depressive disorder. Front Hum Neurosci. 2018;12:108. https://doi.org/10.3389/fnhum.2018.00108
  78. Morgan JA, Olagunju AT, Corrigan F, Baune BT. Does ceasing exercise induce depressive symptoms? A systematic review of experimental trials including immunological and neurogenic markers. J Affect Disord. 2018;234:180-192. https://doi.org/10.1016/j.jad.2018.02.058
  79. Krivoschekov SG, Lushnikov ON. The functional state of athletes addicted to exercises during exercise deprivation. Human Physiology. 2017;43(6):80-87. (In Russ.) https://doi.org/10.7868/S0131164617040075
  80. Weinstein A, Weinstein Y. Exercise addiction- diagnosis, bio-psychological mechanisms and treatment issues. Current Pharmaceutical Design. 2014;20(25):4062-4069. https://doi.org/10.2174/13816128113199990614

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.